bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplemental Figure 1 from Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
Authors: Chicard Mathieu , Boyault Sandrine , Colmet Daage Leo , Richer Wilfrid , Gentien David , Pierron Gaelle , Lapouble Eve , Bellini Angela , Clement Nathalie , Iacono Isabelle , Bréjon Stéphanie , Carrere Marjorie , Reyes Cécile , Hocking Toby , Bernard Virginie , Peuchmaur Michel , Corradini Nadège , Faure-Conter Cécile , Coze Carole , Plantaz Dominique , Defachelles Anne Sophie , Thebaud Estelle , Gambart Marion , Millot Frédéric , Valteau-Couanet Dominique , Michon Jean , Puisieux Alain , Delattre Olivier , Combaret Valérie , Schleiermacher Gudrun
Published: April 2023

Quality control of cfDNA
Supplementary data from Non-Hodgkin and Hodgkin Lymphomas Select for Overexpression of BCLW
Authors: Adams Clare M. , Mitra Ramkrishna , Gong Jerald Z. , Eischen Christine M.
Published: April 2023

Supplementary figures, legends, and tables: Supplementary Figure 1. Pathologist scoring of BCLW and BCL2 IHC; Supplementary Figure 2. BCLW expression does not correlate with BCL2 in GCB DLBCL and does not predict survival of ABC DLBCL; Supplementary Figure 3. BCLW and BCL2 are overexpressed at a similar frequency in follicular lymphoma; Supplementary Figure 4. Marginal zone lymphomas frequently overexpress BCLW; Supplementary Figure 5. BCLW is overexpressed in mantle cell lymphoma; Supplementary Figure 6. Hodgkin lymphoma preferentially selects for BCLW overexpression; Supplementary Figure 7. Expression of anti-apoptotic BCL2 family members in follicular lymphoma; Supplementary Figure 8. Validation of BCLW overexpression in DLBCL; Supplementary Table 1. Microarray gene expression profiling datasets; Supplementary Table 2. Significantly inversely correlated gene pairs.
Suppl Tables from MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases
Authors: Bai Xue , Kong Yan , Chi Zhihong , Sheng Xinan , Cui Chuanliang , Wang Xuan , Mao Lili , Tang Bixia , Li Siming , Lian Bin , Yan Xieqiao , Zhou Li , Dai Jie , Guo Jun , Si Lu
Published: April 2023

Tab S1-S18
Figure S1 from In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The ϕ-Index
Authors: Bakas Spyridon , Akbari Hamed , Pisapia Jared , Martinez-Lage Maria , Rozycki Martin , Rathore Saima , Dahmane Nadia , O'Rourke Donald M. , Davatzikos Christos
Published: April 2023

Scatter plot of the Peritumoral Heterogeneity Index (PHI) in y axis over the median Euclidean distance between the near and far ROI for each patient, by EGFRvIII expression status across 142 patients. We note that PHI is uncorrelated to the distance of the ROIs (correlation coefficient: 0.0519, p-value=0.5394).
Supplementary Figure 2: CTCAE of liver tests for HDCT from The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer Subjects
Authors: Mansfield Aaron S. , Rudek Michelle A. , Vulih Diana , Smith Gary L. , Harris Pamela Jo , Ivy S. Percy
Published: April 2023

The peak CTCAE of liver tests for HDCT subjects are shown above. Amongst HDCT, there were higher CTCAE grades for alkaline phosphatase (p<0.01) and total bilirubin (p=0.01) amongst subjects receiving hepatotoxic agents than non-toxic agents. No differences were seen in CTCAE scores for AST and ALT based on type of agent.
Supplementary Table 3 from Interleukin-17–Producing Neutrophils Link Inflammatory Stimuli to Disease Progression by Promoting Angiogenesis in Gastric Cancer
Authors: Li Tuan-Jie , Jiang Yu-Ming , Hu Yan-Feng , Huang Lei , Yu Jiang , Zhao Li-Ying , Deng Hai-Jun , Mou Ting-Yu , Liu Hao , Yang Yang , Zhang Qi , Li Guo-Xin
Published: April 2023

Association of CD66b+ cells in IM and TC with clinicopathological characteristics.
Supplemental legend from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
Authors: Song Kyung-A , Niederst Matthew J. , Lochmann Timothy L. , Hata Aaron N. , Kitai Hidenori , Ham Jungoh , Floros Konstantinos V. , Hicks Mark A. , Hu Haichuan , Mulvey Hillary E. , Drier Yotam , Heisey Daniel A.R. , Hughes Mark T. , Patel Neha U. , Lockerman Elizabeth L. , Garcia Angel , Gillepsie Shawn , Archibald Hannah L. , Gomez-Caraballo Maria , Nulton Tara J. , Windle Brad E. , Piotrowska Zofia , Sahingur Sinem E. , Taylor Shirley M. , Dozmorov Mikhail , Sequist Lecia V. , Bernstein Bradley , Ebi Hiromichi , Engelman Jeffrey A. , Faber Anthony C.
Published: April 2023

Supplemental legend
SI Table 1 from Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM
Authors: Song Kyung-A , Niederst Matthew J. , Lochmann Timothy L. , Hata Aaron N. , Kitai Hidenori , Ham Jungoh , Floros Konstantinos V. , Hicks Mark A. , Hu Haichuan , Mulvey Hillary E. , Drier Yotam , Heisey Daniel A.R. , Hughes Mark T. , Patel Neha U. , Lockerman Elizabeth L. , Garcia Angel , Gillepsie Shawn , Archibald Hannah L. , Gomez-Caraballo Maria , Nulton Tara J. , Windle Brad E. , Piotrowska Zofia , Sahingur Sinem E. , Taylor Shirley M. , Dozmorov Mikhail , Sequist Lecia V. , Bernstein Bradley , Ebi Hiromichi , Engelman Jeffrey A. , Faber Anthony C.
Published: April 2023

Top 10 correlated genes to BIM (BCL2L11)
Supplementary Tables from LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab
Authors: Bonanno Laura , De Paoli Angela , Zulato Elisabetta , Esposito Giovanni , Calabrese Fiorella , Favaretto Adolfo , Santo Antonio , Conte Alessandro Del , Chilosi Marco , Oniga Francesco , Sozzi Gabriella , Moro Massimo , Ciccarese Francesco , Nardo Giorgia , Bertorelle Roberta , Candiotto Cinzia , De Salvo Gian Luca , Amadori Alberto , Conte PierFranco , Indraccolo Stefano
Published: April 2023

Bonanno L. et al. Supplementary Tables
Supplementary Table 6 from Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets
Authors: Rekhtman Natasha , Pietanza Maria C. , Hellmann Matthew D. , Naidoo Jarushka , Arora Arshi , Won Helen , Halpenny Darragh F. , Wang Hangjun , Tian Shaozhou K. , Litvak Anya M. , Paik Paul K. , Drilon Alexander E. , Socci Nicholas , Poirier John T. , Shen Ronglai , Berger Michael F. , Moreira Andre L. , Travis William D. , Rudin Charles M. , Ladanyi Marc
Published: April 2023

Supplementary Table 6: Complete list of potentially-actionable alterations
Supplementary Table 4 from Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets
Authors: Rekhtman Natasha , Pietanza Maria C. , Hellmann Matthew D. , Naidoo Jarushka , Arora Arshi , Won Helen , Halpenny Darragh F. , Wang Hangjun , Tian Shaozhou K. , Litvak Anya M. , Paik Paul K. , Drilon Alexander E. , Socci Nicholas , Poirier John T. , Shen Ronglai , Berger Michael F. , Moreira Andre L. , Travis William D. , Rudin Charles M. , Ladanyi Marc
Published: April 2023

Supplementary Table 4: Complete list of mutations and copy number alterations detected by MSK-IMPACT in 45 LCNECs
Supplemental Figure 2 Clonal progression of P02 and P04. from Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non–Small Cell Lung Cancer
Authors: Li Anna , Yang Jin-ji , Zhang Xu-chao , Zhang Zhou , Su Jian , Gou Lan-ying , Bai Yu , Zhou Qing , Yang Zhenfan , Han-Zhang Han , Zhong Wen-Zhao , Chuai Shannon , Zhang Qi , Xie Zhi , Gao Hongfei , Chen Huajun , Wang Zhen , Wang Zheng , Yang Xue-ning , Wang Bin-chao , Gan Bin , Chen Zhi-hong , Jiang Ben-yuan , Wu Si-pei , Liu Si-yang , Xu Chong-rui , Wu Yi-long
Published: April 2023

Schematic diagram of clonal evolution of P02 and P04. P02 carried baseline EGFR L858R and subsequently developed MET amplification at PD after EGFR-TKI exposure. After swithiching to EGFR-TKI plus MET-TKI, this patient developed MET Y1248H and D1246N at PD accompaied by EGFR T790M. P04 carried baseline EGFR 19 del and subsequent MET amplification at PD after EGFR-TKI. This patient also acquired MET D1246N at PD after swtiching to EGFR-TKI plus MET-TKI.
Supplementary Tables S1-S8 from Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy
Authors: Kong Yan , Sheng Xinan , Wu Xiaowen , Yan Junya , Ma Meng , Yu Jiayi , Si Lu , Chi Zhihong , Cui Chuanliang , Dai Jie , Li Yiqian , Yu Huan , Xu Tianxiao , Tang Huan , Tang Bixia , Mao Lili , Lian Bin , Wang Xuan , Yan Xieqiao , Li Siming , Guo Jun
Published: April 2023

Supplementary Table S1. Genetic aberrations of cells used in this study Supplementary Table S2. Clinicopathological features and genetic aberrations of established PDX models used in this study Supplementary Table S3. Detailed clinicopathological features and genetic aberrations of patients Supplementary Table S4. Validation of copy number variations of genes related to CDK4 pathway by Q-PCR and mutation status of therapeutic targets Supplementary Table S5. Correlation between copy number variations and protein expression of CDK4 pathway in acral melanoma Supplementary Table S6. Correlation of concurrent CDK4 pathway aberrations to clinicopathologic features of acral melanoma Supplementary Table S7. Univariate and multivariate analysis of risk factors associated with overall survival Supplementary Table S8. Correlation of concurrent CDK4 pathway aberrations to mitotic rate and TILs score of acral melanoma
Supplementary Table 1 from An Open-Label, Dose–Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma
Authors: Khalil Danny N. , Postow Michael A. , Ibrahim Nageatte , Ludwig Dale L. , Cosaert Jan , Kambhampati Siva Rama Prasad , Tang Shande , Grebennik Dmitri , Kauh John Sae Wook , Lenz Heinz-Josef , Flaherty Keith T. , Hodi F. Stephen , Lawrence Donald P. , Wolchok Jedd D.
Published: April 2023

Summary of TEAE by system organ class (SOC) grade greater than or equal to 3. Number of patients (%)
Supplementary Tables 2 from Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer
Authors: Dunne Philip D. , McArt Darragh G. , Bradley Conor A. , O'Reilly Paul G. , Barrett Helen L. , Cummins Robert , O'Grady Tony , Arthur Ken , Loughrey Maurice B. , Allen Wendy L. , McDade Simon S. , Waugh David J. , Hamilton Peter W. , Longley Daniel B. , Kay Elaine W. , Johnston Patrick G. , Lawler Mark , Salto-Tellez Manuel , Van Schaeybroeck Sandra
Published: April 2023

Supplementary Table 2: Differentially expressed gene list contrasting tumour region of origin between Central Tumor and Invasive Front. Supplementary Table 3: Differentially expressed gene list contrasting tumour region of origin between CT-LN. Supplementary Table 4: Differentially expressed gene list contrasting tumour region of origin between LN-IF.
Supplementary Table 3 from Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer
Authors: Dunne Philip D. , McArt Darragh G. , Bradley Conor A. , O'Reilly Paul G. , Barrett Helen L. , Cummins Robert , O'Grady Tony , Arthur Ken , Loughrey Maurice B. , Allen Wendy L. , McDade Simon S. , Waugh David J. , Hamilton Peter W. , Longley Daniel B. , Kay Elaine W. , Johnston Patrick G. , Lawler Mark , Salto-Tellez Manuel , Van Schaeybroeck Sandra
Published: April 2023

Supplementary Table 3: Differentially expressed gene list contrasting tumour region of origin between Central Tumor and Lymph Node.
Supplemental Figure 3 from Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
Authors: Van Roosbroeck Katrien , Fanini Francesca , Setoyama Tetsuro , Ivan Cristina , Rodriguez-Aguayo Cristian , Fuentes-Mattei Enrique , Xiao Lianchun , Vannini Ivan , Redis Roxana S. , D'Abundo Lucilla , Zhang Xinna , Nicoloso Milena S. , Rossi Simona , Gonzalez-Villasana Vianey , Rupaimoole Rajesha , Ferracin Manuela , Morabito Fortunato , Neri Antonino , Ruvolo Peter P. , Ruvolo Vivian R. , Pecot Chad V. , Amadori Dino , Abruzzo Lynne , Calin Steliana , Wang Xuemei , You M. James , Ferrajoli Alessandra , Orlowski Robert , Plunkett William , Lichtenberg Tara M. , Davuluri Ramana V. , Berindan-Neagoe Ioana , Negrini Massimo , Wistuba Ignacio I. , Kantarjian Hagop M. , Sood Anil K. , Lopez-Berestein Gabriel , Keating Michael J. , Fabbri Muller , Calin George A.
Published: April 2023

Clinical correlation of miR-155 expression with survival in leukemia. Kaplan-Meier survival analysis for patients expressing high levels of miR-155 vs. low levels of miR-155 in two CLL cohorts, CLL - NEJM (A) and CLL - Italy (B), and in one ALL cohort, ALL - MDACC (C).
Supplemental Figure 3 from Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients
Authors: Castiello Luciano , Sabatino Marianna , Ren Jiaqiang , Terabe Masaki , Khuu Hanh , Wood Lauren V. , Berzofsky Jay A. , Stroncek David F.
Published: April 2023

Interactive 3D plot showing the correlation of module 2 expression with CD14, IL-10, MDC and MCP-1.Each dot represents one DC sample. X, y and z coordinates represent concentration levels of IL-10, MDC, and MCP-1, respectively, size of dots is proportional with % of CD14+ cells, color represents module 2 expression level (red-yellow-white gradient, with red being the lowest expression level and white the highest)
Supplemental Figure 2 from Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients
Authors: Castiello Luciano , Sabatino Marianna , Ren Jiaqiang , Terabe Masaki , Khuu Hanh , Wood Lauren V. , Berzofsky Jay A. , Stroncek David F.
Published: April 2023

Response Predictive Ability of secreted IL-12/IL-10 ratio
SI from Myeloma Cell Dynamics in Response to Treatment Supports a Model of Hierarchical Differentiation and Clonal Evolution
Authors: Tang Min , Zhao Rui , van de Velde Helgi , Tross Jennifer G. , Mitsiades Constantine , Viselli Suzanne , Neuwirth Rachel , Esseltine Dixie-Lee , Anderson Kenneth , Ghobrial Irene M. , San Miguel Jesús F. , Richardson Paul G. , Tomasson Michael H. , Michor Franziska
Published: April 2023

Supplementary Information
Table S5 from The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma
Authors: Cooke Susanna L. , Ennis Darren , Evers Lisa , Dowson Suzanne , Chan Mei Yen , Paul James , Hirschowitz Lynn , Glasspool Rosalind M. , Singh Naveena , Bell Sarah , Day Elizabeth , Kochman Agata , Wilkinson Nafisa , Beer Philip , Martin Sancha , Millan David , Biankin Andrew V. , McNeish Iain A.
Published: April 2023

Quantitative PCR results for high risk HPV genotypes
Figure S6 from The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma
Authors: Cooke Susanna L. , Ennis Darren , Evers Lisa , Dowson Suzanne , Chan Mei Yen , Paul James , Hirschowitz Lynn , Glasspool Rosalind M. , Singh Naveena , Bell Sarah , Day Elizabeth , Kochman Agata , Wilkinson Nafisa , Beer Philip , Martin Sancha , Millan David , Biankin Andrew V. , McNeish Iain A.
Published: April 2023

Zygosity estimates for the three MCT samples that also had some degree of copy number alteration
Supplementary Figure 4 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
Authors: Lamberts Laetitia E. , Koch Maximillian , de Jong Johannes S. , Adams Arthur L.L. , Glatz Jürgen , Kranendonk Mariëtte E.G. , Terwisscha van Scheltinga Anton G.T. , Jansen Liesbeth , de Vries Jakob , Lub-de Hooge Marjolijn N. , Schröder Carolien P. , Jorritsma-Smit Annelies , Linssen Matthijs D. , de Boer Esther , van der Vegt Bert , Nagengast Wouter B. , Elias Sjoerd G. , Oliveira Sabrina , Witkamp Arjen J. , Mali Willem P.Th.M. , Van der Wall Elsken , van Diest Paul J. , de Vries Elisabeth G.E. , Ntziachristos Vasilis , van Dam Gooitzen M.
Published: April 2023

Co-localization of Bevacizumab-IRDye800CW, hematoxylin/eosin (H/E), VEGF-A, Collagen and CD34 in Breast Cancer and a Satellite Lesion.
Supplementary Figure 3 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
Authors: Lamberts Laetitia E. , Koch Maximillian , de Jong Johannes S. , Adams Arthur L.L. , Glatz Jürgen , Kranendonk Mariëtte E.G. , Terwisscha van Scheltinga Anton G.T. , Jansen Liesbeth , de Vries Jakob , Lub-de Hooge Marjolijn N. , Schröder Carolien P. , Jorritsma-Smit Annelies , Linssen Matthijs D. , de Boer Esther , van der Vegt Bert , Nagengast Wouter B. , Elias Sjoerd G. , Oliveira Sabrina , Witkamp Arjen J. , Mali Willem P.Th.M. , Van der Wall Elsken , van Diest Paul J. , de Vries Elisabeth G.E. , Ntziachristos Vasilis , van Dam Gooitzen M.
Published: April 2023

Microscopic Biodistribution of Bevacizumab-IRDye800CW
Supplemental Table 2 from Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
Authors: Balli David , Rech Andrew J. , Stanger Ben Z. , Vonderheide Robert H.
Published: April 2023

GISTIC all lesions
Table S6 from Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
Authors: Sun Jie , Meng Hua , Yao Lu , Lv Meng , Bai Jian , Zhang Jianguang , Wang Lientu , Ouyang Tao , Li Jinfeng , Wang Tianfeng , Fan Zhaoqing , Fan Tie , Lin Benyao , Xie Yuntao
Published: April 2023

Univariate Analyses of Disease-free Survival and Disease-specific Survival
Table S2 from Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
Authors: Sun Jie , Meng Hua , Yao Lu , Lv Meng , Bai Jian , Zhang Jianguang , Wang Lientu , Ouyang Tao , Li Jinfeng , Wang Tianfeng , Fan Zhaoqing , Fan Tie , Lin Benyao , Xie Yuntao
Published: April 2023

Clinical Characteristics
Figure S8 from Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation
Authors: Kapoor Shivani , Natarajan Karthika , Baldwin Patrick R. , Doshi Kshama A. , Lapidus Rena G. , Mathias Trevor J. , Scarpa Mario , Trotta Rossana , Davila Eduardo , Kraus Manfred , Huszar Dennis , Tron Adriana E. , Perrotti Danilo , Baer Maria R.
Published: April 2023

The USP9X inhibitor WP1130 enhances induction of apoptosis of Ba/F3-ITD and MV4-11 cells by quizartinib in a concentration-dependent manner.
Supplemental Table 7 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
Authors: Thompson Jeffrey C. , Yee Stephanie S. , Troxel Andrea B. , Savitch Samantha L. , Fan Ryan , Balli David , Lieberman David B. , Morrissette Jennifer D. , Evans Tracey L. , Bauml Joshua , Aggarwal Charu , Kosteva John A. , Alley Evan , Ciunci Christine , Cohen Roger B. , Bagley Stephen , Stonehouse-Lee Susan , Sherry Victoria E. , Gilbert Elizabeth , Langer Corey , Vachani Anil , Carpenter Erica L.
Published: April 2023

Analysis of discordant EGFR driver and resistance mutations detected in tDNA or ctDNA
Supplemental Table 6 from Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
Authors: Thompson Jeffrey C. , Yee Stephanie S. , Troxel Andrea B. , Savitch Samantha L. , Fan Ryan , Balli David , Lieberman David B. , Morrissette Jennifer D. , Evans Tracey L. , Bauml Joshua , Aggarwal Charu , Kosteva John A. , Alley Evan , Ciunci Christine , Cohen Roger B. , Bagley Stephen , Stonehouse-Lee Susan , Sherry Victoria E. , Gilbert Elizabeth , Langer Corey , Vachani Anil , Carpenter Erica L.
Published: April 2023

Allelic fractions for all variants detected in tDNA and ctDNA* in patients for whom both plasma and tissue samples were obtained (n=50)
Supplementary Table S1 from First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors
Authors: Demetri George D. , Luke Jason J. , Hollebecque Antoine , Powderly John D. , Spira Alexander I. , Subbiah Vivek , Naumovski Louie , Chen Chris , Fang Hua , Lai Dominic W. , Yue Huibin , Polepally Akshanth R. , Purcell James W. , Robinson Randy , Sharma Padmanee , Allison James P. , Tolcher Anthony , Villalobos Victor M.
Published: April 2023

Supplementary Table S1 shows inclusion and exclusion criteria for each treatment arm that enrolled patients
Supplementary Figure 5 from Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results
Authors: Pidala Joseph , Walton Kelly , Elmariah Hany , Kim Jongphil , Mishra Asmita , Bejanyan Nelli , Nishihori Taiga , Khimani Farhad , Perez Lia , Faramand Rawan G. , Davila Marco L. , Nieder Michael L. , Sagatys Elizabeth M. , Holtan Shernan G. , Lawrence Nicholas J. , Lawrence Harshani R. , Blazar Bruce R. , Anasetti Claudio , Sebti Said M. , Betts Brian C.
Published: April 2023

Impact of JAK2/mTOR blockade on human T cell responses toward CMV, EBV, Influenza, and tetanus stimulation. A, B) Graphs show the recall proliferation of CD4+ and CD8+ T cell proliferation in response to CEFT peptides. C, D) Graph shows the frequency of IFNy+, CD107a+ CD4+ or cos+ T cells after stimulation with CEFT peptides.
Table S5 from Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
Authors: Ferrara Roberto , Naigeon Marie , Auclin Edouard , Duchemann Boris , Cassard Lydie , Jouniaux Jean-Mehdi , Boselli Lisa , Grivel Jonathan , Desnoyer Aude , Mezquita Laura , Texier Matthieu , Caramella Caroline , Hendriks Lizza , Planchard David , Remon Jordi , Sangaletti Sabina , Proto Claudia , Garassino Marina C. , Soria Jean-Charles , Marabelle Aurelien , Voisin Anne-Laure , Farhane Siham , Besse Benjamin , Chaput Nathalie
Published: April 2023

Phenotypic characterization of CD4+ TH and CD8+ TC cell subsets and OX40+ Treg cells
Supplementary Methods from Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
Authors: Ferrara Roberto , Naigeon Marie , Auclin Edouard , Duchemann Boris , Cassard Lydie , Jouniaux Jean-Mehdi , Boselli Lisa , Grivel Jonathan , Desnoyer Aude , Mezquita Laura , Texier Matthieu , Caramella Caroline , Hendriks Lizza , Planchard David , Remon Jordi , Sangaletti Sabina , Proto Claudia , Garassino Marina C. , Soria Jean-Charles , Marabelle Aurelien , Voisin Anne-Laure , Farhane Siham , Besse Benjamin , Chaput Nathalie
Published: April 2023

Supplementary Methods
Supplementary Data from Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)
Authors: Johnson Douglas B. , Zhao Fengmin , Noel Marcus , Riely Gregory J. , Mitchell Edith P. , Wright John J. , Chen Helen X. , Gray Robert J. , Li Shuli , McShane Lisa M. , Rubinstein Larry V. , Patton David , Williams P. Mickey , Hamilton Stanly R. , Conley Barbara A. , Arteaga Carlos L. , Harris Lyndsay N. , O'Dwyer Peter J. , Chen Alice P. , Flaherty Keith T.
Published: April 2023

Supplementary Figure 1: "Lollipop" plot demonstrating the number and locations of BRAF mutations identified in study patients. RBD: Ras-binding domain. BRAF fusion not pictured.
Supplementary Figures from Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma
Authors: Holt Jeremiah , Walter Vonn , Yin Xiaoying , Marron David , Wilkerson Matthew D. , Choi Hyo Young , Zhao Xiaobei , Jo Heejoon , Hayes David Neil , Ko Yoon Ho
Published: April 2023

Supplementary Figures and Legends
Supplementary Table S6 from Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Authors: Laumont Céline M. , Wouters Maartje C.A. , Smazynski Julian , Gierc Nicole S. , Chavez Elizabeth A. , Chong Lauren C. , Thornton Shelby , Milne Katy , Webb John R. , Steidl Christian , Nelson Brad H.
Published: April 2023

Supplementary Table S6 presents relevant information pertaining to the antibodies used in the 5-color immunofluorescence panel.
Figure S5 from An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
Authors: Bai Yalai , Cole Kimberly , Martinez-Morilla Sandra , Ahmed Fahad Shabbir , Zugazagoitia Jon , Staaf Johan , Bosch Ana , Ehinger Anna , Nimeus Emma , Hartman Johan , Acs Balazs , Rimm David L.
Published: April 2023

Associations between pathologist-read-sTIL scores with matched easTILs
Table S3 from Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial
Authors: Li Dapeng , Chi Yihebali , Chen Xiaohong , Ge Minghua , Zhang Yuan , Guo Zhuming , Wang Jun , Chen Jie , Zhang Jiewu , Cheng Ying , Li Zhendong , Liu Hui , Qin Jianwu , Zhu Jingqiang , Cheng Ruochuan , Xu Zhengang , Zheng Xiangqian , Tang Pingzhang , Gao Ming
Published: April 2023

Best calcitonin biochemical response
Supplementary Legend from Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types
Authors: van der Wijngaart Hanneke , Hoes Louisa R. , van Berge Henegouwen J. Maxime , van der Velden Daphne L. , Zeverijn Laurien J. , Roepman Paul , van Werkhoven Erik , de Leng Wendy W.J. , Jansen Anne M.L. , Mehra Niven , Robbrecht Debbie G.J. , Labots Mariette , de Groot Derk Jan A. , Hoeben Ann , Hamberg Paul , Gelderblom Hans , Voest Emile E. , Verheul Henk M.W.
Published: April 2023

Supplementary Legend
Supplemental Figure 2 from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma
Authors: Tuscano Joseph M. , Poh Christina , Kaesberg Paul , Luxardi Guilluame , Merleev Alexander , Marusina Alina , Brunson Ann , Rosenberg Aaron , Jonas Brian , Maverakis Emanual
Published: April 2023

Gating strategy for analysis of live lymphocytes.
Supplementary Data from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
Authors: Kurani Hetakshi , Razavipour Seyedeh Fatemeh , Harikumar Kuzhuvelil B. , Dunworth Matthew , Ewald Andrew J. , Nasir Apsra , Pearson Gray , Van Booven Derek , Zhou Zhiqun , Azzam Diana , Wahlestedt Claes , Slingerland Joyce
Published: April 2023

Supplementary Data from DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
Table S2 from Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma
Authors: Waldschmidt Johannes M. , Kloeber Jake A. , Anand Praveen , Frede Julia , Kokkalis Antonis , Dimitrova Valeriya , Potdar Sayalee , Nair Monica S. , Vijaykumar Tushara , Im Nam Gyu , Guillaumet-Adkins Amy , Chopra Nitish , Stuart Hannah , Budano Lillian , Sotudeh Noori , Guo Guangwu , Grassberger Clemens , Yee Andrew J. , Laubach Jacob P. , Richardson Paul G. , Anderson Kenneth C. , Raje Noopur S. , Knoechel Birgit , Lohr Jens G.
Published: April 2023

Antibodies used for Western Blot experiments
Figure S9 from Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma
Authors: Waldschmidt Johannes M. , Kloeber Jake A. , Anand Praveen , Frede Julia , Kokkalis Antonis , Dimitrova Valeriya , Potdar Sayalee , Nair Monica S. , Vijaykumar Tushara , Im Nam Gyu , Guillaumet-Adkins Amy , Chopra Nitish , Stuart Hannah , Budano Lillian , Sotudeh Noori , Guo Guangwu , Grassberger Clemens , Yee Andrew J. , Laubach Jacob P. , Richardson Paul G. , Anderson Kenneth C. , Raje Noopur S. , Knoechel Birgit , Lohr Jens G.
Published: April 2023

Dabrafenib sensitivity in DP6 single clones
Figure S11 from Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma
Authors: Waldschmidt Johannes M. , Kloeber Jake A. , Anand Praveen , Frede Julia , Kokkalis Antonis , Dimitrova Valeriya , Potdar Sayalee , Nair Monica S. , Vijaykumar Tushara , Im Nam Gyu , Guillaumet-Adkins Amy , Chopra Nitish , Stuart Hannah , Budano Lillian , Sotudeh Noori , Guo Guangwu , Grassberger Clemens , Yee Andrew J. , Laubach Jacob P. , Richardson Paul G. , Anderson Kenneth C. , Raje Noopur S. , Knoechel Birgit , Lohr Jens G.
Published: April 2023

Transcriptional activation of oxidative phosphorylation pathway genes in U266 dabrafenib-persistent cells
Supplementary Figure S1 from Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability–High/Mismatch Repair–Deficient Tumors
Authors: Hollebecque Antoine , Chung Hyun C. , de Miguel Maria J. , Italiano Antoine , Machiels Jean-Pascal , Lin Chia-Chi , Dhani Neesha C. , Peeters Marc , Moreno Victor , Su Wu-Chou , Chow Kay Hoong , Galvao Violeta R. , Carlsen Michelle , Yu Danni , Szpurka Anna M. , Zhao Yumin , Schmidt Shelly L. , Gandhi Leena , Xu Xiaojian , Bang Yung-Jue
Published: April 2023

Figure S1. Progression-free survival
Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma
Authors: Esteban-Fabró Roger , Willoughby Catherine E. , Piqué-Gili Marta , Montironi Carla , Abril-Fornaguera Jordi , Peix Judit , Torrens Laura , Mesropian Agavni , Balaseviciute Ugne , Miró-Mur Francesc , Mazzaferro Vincenzo , Pinyol Roser , Llovet Josep M.
Published: April 2023

Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma
Figure S3 from High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9
Authors: Majumder Shounak , Taylor William R. , Foote Patrick H. , Berger Calise K. , Wu Chung Wah , Mahoney Douglas W. , Bamlet William R. , Burger Kelli N. , Postier Neil , de la Fuente Jaime , Doering Karen A. , Lidgard Graham P. , Allawi Hatim T. , Petersen Gloria M. , Chari Suresh T. , Ahlquist David A. , Kisiel John B.
Published: April 2023

Supplemental Figure 3 shows the distributions in plasma from controls and PDAC patients by stage of disease and standardized copy numbers of all MDMs other than HOXA1 and PRKCB.
Figure S2 from High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9
Authors: Majumder Shounak , Taylor William R. , Foote Patrick H. , Berger Calise K. , Wu Chung Wah , Mahoney Douglas W. , Bamlet William R. , Burger Kelli N. , Postier Neil , de la Fuente Jaime , Doering Karen A. , Lidgard Graham P. , Allawi Hatim T. , Petersen Gloria M. , Chari Suresh T. , Ahlquist David A. , Kisiel John B.
Published: April 2023

Supplemental Figure 2 shows the correlation between CA 19-9 values derived using study protocol and clinical laboratory values derived at Mayo Clinic.
Supplementary Table S2 from A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2–Induced Glycolytic Reprogramming in Glioblastoma
Authors: Beinat Corinne , Patel Chirag B. , Haywood Tom , Murty Surya , Naya Lewis , Castillo Jessa B. , Reyes Samantha T. , Phillips Megan , Buccino Pablo , Shen Bin , Park Jun Hyung , Koran Mary Ellen I. , Alam Israt S. , James Michelle L. , Holley Dawn , Halbert Kim , Gandhi Harsh , He Joy Q. , Granucci Monica , Johnson Eli , Liu Daniel Dan , Uchida Nobuko , Sinha Rahul , Chu Pauline , Born Donald E. , Warnock Geoffrey I. , Weissman Irving , Hayden-Gephart Melanie , Khalighi Mehdi , Massoud Tarik F. , Iagaru Andrei , Davidzon Guido , Thomas Reena , Nagpal Seema , Recht Lawrence D. , Gambhir Sanjiv Sam
Published: April 2023

[18F]DASA-23 administered activity in brain tumor patients
Supplementary Table 1 from A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma
Authors: Angeles Christina V. , Velez Ana , Rios Jordan , Laxa Bernadette , Shum David , Ruiz Penelope D. , Shen Yawei , Ostrovnaya Irina , Gularte-Mérida Rodrigo , Nacev Benjamin A. , Dickson Mark A. , Djaballah Hakim , Okada Tomoyo , Singer Samuel
Published: April 2023

List of compounds used in the screen
Supplementary Figures from Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma
Authors: Birnbaum David J. , Begg Sebastian K.S. , Finetti Pascal , Vanderburg Charles , Kulkarni Anupriya S. , Neyaz Azfar , Hank Thomas , Tai Eric , Deshpande Vikram , Bertucci François , Birnbaum Daniel , Lillemoe Keith D. , Warshaw Andrew L. , Mino-Kenudson Mari , Fernandez-Del Castillo Carlos , Ting David T. , Liss Andrew S.
Published: April 2023

Figures S1-S6
Supplementary Tables from Development and Multiple Validation of the Protein Multi-marker Panel for Diagnosis of Pancreatic Cancer
Authors: Kim Yoseop , Yeo Injoon , Huh Iksoo , Kim Jaenyeon , Han Dohyun , Jang Jin-Young , Kim Youngsoo
Published: April 2023

Supplementary Tables 1-8.
Supplementary Fig. S4 from Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies
Authors: Liang Yi , Jeganathan Sujeeve , Marastoni Stefano , Sharp Adam , Figueiredo Ines , Marcellus Richard , Mawson Amanda , Shalev Zvi , Pesic Aleksandra , Sweet Joan , Guo Haiyang , Uehling David , Gurel Bora , Neeb Antje , He Housheng Hansen , Montgomery Bruce , Koritzinsky Marianne , Oakes Samantha , de Bono Johann S. , Gleave Martin , Zoubeidi Amina , Wouters Bradly G. , Joshua Anthony M.
Published: April 2023

Pharmacological screens identify BCL-2 and IKKB inhibitor that specifically targets ENZ-resistant cell lines
Supplementary Fig. S3 from Emergence of Enzalutamide Resistance in Prostate Cancer is Associated with BCL-2 and IKKB Dependencies
Authors: Liang Yi , Jeganathan Sujeeve , Marastoni Stefano , Sharp Adam , Figueiredo Ines , Marcellus Richard , Mawson Amanda , Shalev Zvi , Pesic Aleksandra , Sweet Joan , Guo Haiyang , Uehling David , Gurel Bora , Neeb Antje , He Housheng Hansen , Montgomery Bruce , Koritzinsky Marianne , Oakes Samantha , de Bono Johann S. , Gleave Martin , Zoubeidi Amina , Wouters Bradly G. , Joshua Anthony M.
Published: April 2023

Characterization of ENZ-resistant cell lines
Supplementary Table from Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia
Authors: Jin Peng , Jin Qiqi , Wang Xiaoling , Zhao Ming , Dong Fangyi , Jiang Ge , Li Zeyi , Shen Jie , Zhang Wei , Wu Shishuang , Li Ran , Zhang Yunxiang , Li Xiaoyang , Li Junmin
Published: April 2023

Supplementary Table from Large-Scale In Vitro and In Vivo CRISPR-Cas9 Knockout Screens Identify a 16-Gene Fitness Score for Improved Risk Assessment in Acute Myeloid Leukemia
Supplementary Figure from Rapid Screening Using Pathomorphologic Interpretation to Detect BRAFV600E Mutation and Microsatellite Instability in Colorectal Cancer
Authors: Fujii Satoshi , Kotani Daisuke , Hattori Masahiro , Nishihara Masato , Shikanai Toshihide , Hashimoto Junji , Hama Yuki , Nishino Takuya , Suzuki Mizuto , Yoshidumi Ayatoshi , Ueno Makoto , Komatsu Yoshito , Masuishi Toshiki , Hara Hiroki , Esaki Taito , Nakamura Yoshiaki , Bando Hideaki , Yamada Tomoyuki , Yoshino Takayuki
Published: April 2023

Supplementary Figure from Rapid Screening Using Pathomorphologic Interpretation to Detect BRAFV600E Mutation and Microsatellite Instability in Colorectal Cancer
Supplementary Figure from A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial
Authors: Hillemanns Peter , Denecke Agnieszka , Woelber Linn , Böhmer Gerd , Jentschke Matthias , Schjetne Karoline W. , Bruins Slot Karsten M.H. , Fredriksen Agnete B.
Published: April 2023

Supplementary Figure from A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial
Supplementary Data from A Mesenchymal Tumor Cell State Confers Increased Dependency on the BCL-XL Antiapoptotic Protein in Kidney Cancer
Authors: Grubb Treg , Maganti Smruthi , Krill-Burger John Michael , Fraser Cameron , Stransky Laura , Radivoyevitch Tomas , Sarosiek Kristopher A. , Vazquez Francisca , Kaelin William G. , Chakraborty Abhishek A.
Published: April 2023

Supplementary Data from A Mesenchymal Tumor Cell State Confers Increased Dependency on the BCL-XL Antiapoptotic Protein in Kidney Cancer
Supplementary Table 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma
Authors: Shoushtari Alexander N. , Olszanski Anthony J. , Nyakas Marta , Hornyak Thomas J. , Wolchok Jedd D. , Levitsky Victor , Kuryk Lukasz , Hansen Thomas B. , Jäderberg Magnus
Published: April 2023

Study representativeness
Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Authors: Bai Jiwei , Shi Jianxin , Zhang Yazhuo , Li Chuzhong , Xiong Yujia , Koka Hela , Wang Difei , Zhang Tongwu , Song Lei , Luo Wen , Zhu Bin , Hicks Belynda , Hutchinson Amy , Kirk Erin , Troester Melissa A. , Li Mingxuan , Shen Yutao , Ma Tianshun , Wang Junmei , Liu Xing , Wang Shuai , Gui Songbai , McMaster Mary L. , Chanock Stephen J. , Parry Dilys M. , Goldstein Alisa M. , Yang Xiaohong R.
Published: April 2023

Figure S2. A. Contributions of small indel (ID) signatures (A and E) between CC1 and CC2; B. Number of mutations in small indel (ID) signatures (A and E) between CC1 and CC2.
Supplementary Figure 1 from Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin against Bladder Cancer by Acting on Mitochondria
Authors: Zeng Jin , Sun Yi , Wu Kaijie , Li Lei , Zhang Gang , Yang Zenglei , Wang Zhiqiang , Zhang Dong , Xue Yan , Chen Yule , Zhu Guodong , Wang Xinyang , He Dalin
Published: April 2023

Supplementary Figure 1 from Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin against Bladder Cancer by Acting on Mitochondria
Supplementary Table S4 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
Authors: Flanagan James M. , Funes Juan M. , Henderson Stephen , Wild Laurence , Carey Nessa , Boshoff Chris
Published: April 2023

Supplementary Table S4 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
Supplementary Fig. S1 from Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion
Authors: Saunders Lauren P. , Ouellette Amy , Bandle Russ , Chang William Chozen , Zhou Hongwen , Misra Raj N. , De La Cruz Enrique M. , Braddock Demetrios T.
Published: April 2023

Supplementary Fig. S1 from Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion
Supplementary Table 1 from Preclinical Studies on the Mechanism of Action and the Anti-Lymphoma Activity of the Novel Anti-CD20 Antibody GA101
Authors: Dalle Stephane , Reslan Lina , Besseyre de Horts Timothee , Herveau Stephanie , Herting Frank , Plesa Adriana , Friess Thomas , Umana Pablo , Klein Christian , Dumontet Charles
Published: April 2023

XLS - 33K, Supplementary Table 1
Supplementary Figure 2 from Modulation of drug resistance by artificial transcription factors
Authors: Blancafort Pilar , Tschan Mario P. , Bergquist Sharon , Guthy Daniel , Brachat Arndt , Sheeter Dennis A. , Torbett Bruce E. , Erdmann Dirk , Barbas Carlos F.
Published: April 2023

Supplementary Figure 2 from Modulation of drug resistance by artificial transcription factors
Supplementary Fig. S3 from Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism
Authors: Payré Bruno , de Medina Philippe , Boubekeur Nadia , Mhamdi Loubna , Bertrand-Michel Justine , Tercé François , Fourquaux Isabelle , Goudounèche Dominique , Record Michel , Poirot Marc , Silvente-Poirot Sandrine
Published: April 2023

Supplementary Fig. S3 from Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism
Supplementary Figure 7 from Anticancer Activity of a Combination of Cisplatin and Fisetin in Embryonal Carcinoma Cells and Xenograft Tumors
Authors: Tripathi Rakshamani , Samadder Tanmoy , Gupta Sarika , Surolia Avadhesha , Shaha Chandrima
Published: April 2023

Supplementary Figure 7 from Anticancer Activity of a Combination of Cisplatin and Fisetin in Embryonal Carcinoma Cells and Xenograft Tumors
Supplementary Material from Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Authors: Maira Sauveur-Michel , Stauffer Frédéric , Brueggen Josef , Furet Pascal , Schnell Christian , Fritsch Christine , Brachmann Saskia , Chène Patrick , De Pover Alain , Schoemaker Kevin , Fabbro Doriano , Gabriel Daniela , Simonen Marjo , Murphy Leon , Finan Peter , Sellers William , García-Echeverría Carlos
Published: April 2023

Supplementary Material from Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Supplementary Fig from Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Authors: Maira Sauveur-Michel , Stauffer Frédéric , Brueggen Josef , Furet Pascal , Schnell Christian , Fritsch Christine , Brachmann Saskia , Chène Patrick , De Pover Alain , Schoemaker Kevin , Fabbro Doriano , Gabriel Daniela , Simonen Marjo , Murphy Leon , Finan Peter , Sellers William , García-Echeverría Carlos
Published: April 2023

Supplementary Fig from Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Supplementary Fig. S1 from A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α
Authors: Li Shan Hua , Shin Dong Hoon , Chun Yang-Sook , Lee Myung Kyu , Kim Myung-Suk , Park Jong-Wan
Published: April 2023

Supplementary Fig. S1 from A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α
Supplementary Fig. S5 from Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Authors: Krynetskaia Natalia F. , Phadke Manali S. , Jadhav Sachin H. , Krynetskiy Evgeny Y.
Published: April 2023

Supplementary Fig. S5 from Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Supplementary Table 1 from RITA Inhibits Multiple Myeloma Cell Growth through Induction of p53-Mediated Caspase-Dependent Apoptosis and Synergistically Enhances Nutlin-Induced Cytotoxic Responses
Authors: Saha Manujendra N. , Jiang Hua , Mukai Asuka , Chang Hong
Published: April 2023

Supplementary Table 1 from RITA Inhibits Multiple Myeloma Cell Growth through Induction of p53-Mediated Caspase-Dependent Apoptosis and Synergistically Enhances Nutlin-Induced Cytotoxic Responses
Supplementary Table S2 from Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy
Authors: Su David M. , Zhang Qiuyang , Wang Xuexi , He Ping , Zhu Yuelin Jack , Zhao Jianxiong , Rennert Owen M. , Su Yan A.
Published: April 2023

Supplementary Table S2 from Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy
Supplementary Material from In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation
Authors: Ikediobi Ogechi N. , Reimers Mark , Durinck Steffen , Blower Paul E. , Futreal Andrew P. , Stratton Michael R. , Weinstein John N.
Published: April 2023

Supplementary Material from In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation
Supplementary Fig. S2 from Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells
Authors: Alfano Randall W. , Leppla Stephen H. , Liu Shihui , Bugge Thomas H. , Herlyn Meenhard , Smalley Keiran S. , Bromberg-White Jennifer L. , Duesbery Nicholas S. , Frankel Arthur E.
Published: April 2023

Supplementary Fig. S2 from Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells
Supplementary Figure Legends 1-2 from Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
Authors: Bruzzese Francesca , Rocco Monia , Castelli Silvia , Di Gennaro Elena , Desideri Alessandro , Budillon Alfredo
Published: April 2023

Supplementary Figure Legends 1-2 from Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
Supplementary Figure 1 from The FLT3 Internal Tandem Duplication Mutation Is a Secondary Target of the Aurora B Kinase Inhibitor AZD1152-HQPA in Acute Myelogenous Leukemia Cells
Authors: Grundy Martin , Seedhouse Claire , Shang Shilli , Richardson Jaineeta , Russell Nigel , Pallis Monica
Published: April 2023

Supplementary Figure 1 from The FLT3 Internal Tandem Duplication Mutation Is a Secondary Target of the Aurora B Kinase Inhibitor AZD1152-HQPA in Acute Myelogenous Leukemia Cells
Supplementary Table 1 from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Authors: Weisberg Ellen , Choi Hwan Geun , Barrett Rosemary , Zhou Wenjun , Zhang Jianming , Ray Arghya , Nelson Erik A. , Jiang Jingrui , Moreno Daisy , Stone Richard , Galinsky Ilene , Fox Edward , Adamia Sophia , Kung Andrew L. , Gray Nathanael S. , Griffin James D.
Published: April 2023

Supplementary Table 1 from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Supplementary Figure Legends from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Authors: Weisberg Ellen , Choi Hwan Geun , Barrett Rosemary , Zhou Wenjun , Zhang Jianming , Ray Arghya , Nelson Erik A. , Jiang Jingrui , Moreno Daisy , Stone Richard , Galinsky Ilene , Fox Edward , Adamia Sophia , Kung Andrew L. , Gray Nathanael S. , Griffin James D.
Published: April 2023

Supplementary Figure Legends from Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Supplementary Video 2 from Endocytosis of PEGylated Agents Enhances Cancer Imaging and Anticancer Efficacy
Authors: Chuang Kuo-Hsiang , Wang Hsin-Ell , Chen Fang-Ming , Tzou Shey-Cherng , Cheng Chiu-Min , Chang Ya-Chen , Tseng Wei-Lung , Shiea Jentaie , Lin Shiu-Ru , Wang Jaw-Yuan , Chen Bing-Mae , Roffler Steve R. , Cheng Tian-Lu
Published: April 2023

Supplementary Video 2 from Endocytosis of PEGylated Agents Enhances Cancer Imaging and Anticancer Efficacy